INSIDE
PULLING BACK THE CURTAIN
Ken Figueroa Shares Her Early Inspiration
GUEST COMMENTARY
Richard Silver Ponders Retirement
WRITTEN IN BLOOD
The Cost of Caplacizumab Outweights Its Benefit in Acquired TTP
The Technicalities of Tech Transfer
More universities and nonprofit organizations are focusing efforts on industry partnerships to bring new therapies to market
EDITOR ’ S CORNER
Aaron Gerds Muses on Medicine and Music
BLOOD ADVANCES IN A DIFFERENT VEIN
Does Blood Group Affect Bleeding Risk ?
PLUS
Late-Breaking Abstracts from the 2020 ASH Annual Meeting